Peroxisome proliferator-activated receptor (PPARs) are ligand-activated transcription factors that exert significant roles in the control of multiple physiological processes. The last decade has shown an increasing interest in the role played by the agonists of PPARs in anti-inflammatory, anti-angiogenic, anti-fibrotic effects and in modulating oxidative stress response in different organs. Since the pathologic mechanisms of the majority of the blinding diseases, such as diabetic retinopathy (DR), age-related macular degeneration (AMD), glaucoma and optic neuropathy (ON), often involve neo-angiogenesis, inflammation and oxidative stress-mediated cell death, evidences are accumulating on the potential benefits of PPAR modulation to prevent o...
Diabetic retinopathy (DR) is a condition that develops after long-lasting and poorly handled diabete...
Worldwide, the prevalence of chronic diseases, such as obesity, diabetes, cardiovascular diseases, c...
The angiogenic, neovascular proliferative retinopathies, proliferative diabetic retinopathy (PDR), a...
Peroxisome proliferator-activated receptor γ (PPAR γ), a member of the nuclear receptor superfamily,...
Peroxisome proliferator-activated receptor a (PPARa) agonism in ocular inflammation has not been tho...
Copyright © 2013 Andreea Ciudin et al.is is an open access article distributed under theCreativeComm...
Diabetic retinopathy, a microvascular complication of diabetes mellitus, is major cause of non-inher...
Diabetic retinopathy (DR) remains as the leading cause of blindness among working age individuals in...
The angiogenic, neovascular proliferative retinopathies, proliferative diabetic retinopathy (PDR), ...
Peroxisome proliferator-activated receptors (PPARs) are ligand dependent transcription factors. The ...
Retinal vascular leakage, inflammation, and neovascularization (NV) are features of diabetic retinop...
Diabetic retinopathy (DR) is one of the most common microvascular complications of diabetes and rema...
Peroxisome proliferator-activated receptor (PPAR)β/δ is a member of the nuclear receptor superfamily...
Peroxisome proliferator-activated receptor (PPAR)β/δ is a member of the nuclear receptor superfamily...
The global pandemic of diabetes mellitus portends an alarming rise in the prevalence of microvascula...
Diabetic retinopathy (DR) is a condition that develops after long-lasting and poorly handled diabete...
Worldwide, the prevalence of chronic diseases, such as obesity, diabetes, cardiovascular diseases, c...
The angiogenic, neovascular proliferative retinopathies, proliferative diabetic retinopathy (PDR), a...
Peroxisome proliferator-activated receptor γ (PPAR γ), a member of the nuclear receptor superfamily,...
Peroxisome proliferator-activated receptor a (PPARa) agonism in ocular inflammation has not been tho...
Copyright © 2013 Andreea Ciudin et al.is is an open access article distributed under theCreativeComm...
Diabetic retinopathy, a microvascular complication of diabetes mellitus, is major cause of non-inher...
Diabetic retinopathy (DR) remains as the leading cause of blindness among working age individuals in...
The angiogenic, neovascular proliferative retinopathies, proliferative diabetic retinopathy (PDR), ...
Peroxisome proliferator-activated receptors (PPARs) are ligand dependent transcription factors. The ...
Retinal vascular leakage, inflammation, and neovascularization (NV) are features of diabetic retinop...
Diabetic retinopathy (DR) is one of the most common microvascular complications of diabetes and rema...
Peroxisome proliferator-activated receptor (PPAR)β/δ is a member of the nuclear receptor superfamily...
Peroxisome proliferator-activated receptor (PPAR)β/δ is a member of the nuclear receptor superfamily...
The global pandemic of diabetes mellitus portends an alarming rise in the prevalence of microvascula...
Diabetic retinopathy (DR) is a condition that develops after long-lasting and poorly handled diabete...
Worldwide, the prevalence of chronic diseases, such as obesity, diabetes, cardiovascular diseases, c...
The angiogenic, neovascular proliferative retinopathies, proliferative diabetic retinopathy (PDR), a...